Optimizer Smart system approved for patients with chronic heart failure not eligible for tx with other devices.
Short-term mortality and readmission rates after acute MI have improved during the last 20 years among Medicare beneficiaries.
Greater scrutiny is needed in evaluating high sensitivity cardiac troponin I levels for the purpose of excluding or diagnosing acute myocardial infarction.
Riociguat has been shown to reduce clinical worsening in patients with technical inoperable and residual chronic thromboembolic pulmonary hypertension.
While 1 in 3 trials on cancer treatment excluded patients with cardiovascular disease, definitions and reasoning for exclusion were not well documented.
Increased risk for heart failure seen in breast cancer survivors given trastuzumab rather than chemo alone.
Suspected pulmonary embolism safely ruled out in some pregnant women with diagnostic algorithm.
A clinician shares his experience with palliative care in cardiology and makes the case for offering palliative care services earlier in pulmonary arterial hypertension.
The sirolimus-eluting Supraflex coronary stent with absorbable polymer coating was noninferior to a currently best-in-class drug-eluting stent at 12 months.
Rivaroxaban found to reduce risk of stroke.
Researchers found a low rate of recurrent stroke after carotid and vertebral dissection and no difference between antiplatelet agents and anticoagulants.
Researchers found that patients who have atrial fibrillation are more likely to have a history of depression than patients who do not.
Balloon pulmonary angioplasty was considered safe and effective even in patients considered “oldest-old” with chronic thromboembolic pulmonary hypertension.
Researchers found that patients with coronary artery disease enrolled in Medicare Advantage had a slightly higher comorbidity burden and received higher quality care than their traditional fee-for-service Medicare counterparts.
Patients with depressive symptoms, however mild, face increased mortality risk long after an acute myocardial infarction.
An analysis found comparable clinical outcomes among patients who initiated generics vs those who were treated with brand-name drugs for chronic conditions.
A new granule formulation of Prograf has been made available for the prophylaxis of organ rejection.
The risk for coronary artery disease in patients with asthma-COPD overlap syndrome who used statins was lower regardless of the duration of treatment.
Sleep apnea severity was associated with elevated pulmonary capillary wedge pressure in adults.
Results from the phase 4 AUGUSTUS trial, evaluating apixaban vs vitamin K antagonists in patients with nonvalvular atrial fibrillation and recent ACS and/or undergoing PCI.